Related Experiment Video
Updated: May 26, 2026
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Axl-dependent signalling: a clinical update.
1Department of Medicine, Aab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA. Slava_Korshunov@URMC.rochester.edu
Clinical Science (London, England : 1979)
|December 23, 2011
Summary
The Gas6/Axl pathway, a receptor tyrosine kinase, is upregulated in diseases, promoting cancer and cardiovascular issues. Inhibiting Axl can reduce tumor growth and metastasis.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Axl receptor tyrosine kinase, part of the TAM family, binds to Gas6.
- Axl activation promotes cell survival, migration, and growth via downstream pathways.
- The Gas6/Axl pathway is more active in pathological states than in normal physiology.
Purpose of the Study:
- To review recent advances in Axl receptor biology.
- To focus on the translational aspects of Axl signaling in diseases.
- To highlight Axl's role in cancer, cardiovascular diseases, and autoimmune disorders.
Main Methods:
- Review of current literature on Axl receptor biology.
- Analysis of Axl's downstream signaling pathways.
- Examination of Axl's role in various pathological conditions.
Main Results:
- Axl inhibition reduces tumorigenesis and metastasis.
- Axl signaling contributes to cardiovascular disease progression.
- Axl deficiency in immune cells exacerbates autoimmune disorders.
Conclusions:
- Axl receptor tyrosine kinase is a significant factor in various diseases.
- Targeting Axl offers therapeutic potential for cancer and other conditions.
- Further research is needed on Axl interactions and activation mechanisms in chronic diseases.
Related Concept Videos
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...